FIN
02/03/2015 15:53
SSH
NOT PRICE SENSITIVE
REL: 1553 HRS Finzsoft Solutions Limited
SSH: FIN: SSH Notice - Holliday Group Holdings Limited ("HGH")
DISCLOSURE OF CEASING TO HAVE SUBSTANTIAL HOLDING
Section 279, Financial Markets Conduct Act 2013
TO: NZX Limited
and
TO: Finzsoft Solutions Limited ("FIN")
Date this disclosure made: 2 March 2015
Date last disclosure made: 1 March 2015
Date on which substantial holding ceased: 2 March 2015
Substantial product holder giving disclosure
Full name(s): Holliday Group Holdings (ICT Investments) Limited ("HGH")
Summary of previous substantial holding
Class of quoted voting products: Ordinary shares
Summary for: HGH
For last disclosure:
(a) total number held in class: 5,646,438
(b) total in class: 8,566,163
(c) total percentage held in class: 65.916%
For current holding after ceasing to have substantial holding:
(a) total number held in class: 0
(b) total in class: 8,566,163
(c) total percentage held in class: 0%
Details of transactions and events giving rise to ceasing of substantial
holding
Details of the transactions or other events requiring disclosure: On 27
February 2015, Silverlake HGH Limited made a full takeover offer under the
Takeovers Code to acquire all the equity securities in FIN ("Offer"). A copy
of the Offer document was sent to NZX by Silverlake HGH Limited on 27
February 2015.
On 1 March 2015, HGH, who entered into the lock-up agreement referred to in
the substantial product holder notice filed by HGH on 18 December 2014,
accepted the Offer for its holding of 5,646,438 shares in FIN in accordance
with the terms of that lock-up agreement.
On 2 March 2015, Silverlake HGH Limited declared the Offer unconditional and
paid the consideration of $16,939,314 to HGH for its 5,646,438 shares in FIN.
Legal and beneficial ownership of, and title to, such shares transferred to
Silverlake HGH Limited on such payment being made.
Additional information
Address(es) of substantial product holder(s): 22 Winscombe Street, Belmont,
Auckland, 0622
Contact details: Andrew Holliday
Phone: +64 21 355 492
Email: [email protected]
Name of any other person believed to have given, or believed to be required
to give, a disclosure under the Financial Markets Conduct Act 2013 in
relation to the financial products to which this disclosure relates:
Silverlake HGH Limited.
Certification
I, Andrew Alexander Holliday, certify that, to the best of my knowledge and
belief, the information contained in this disclosure is correct and that I am
duly authorised to make this disclosure by all persons for whom it is made.
End CA:00261349 For:FIN Type:SSH Time:2015-03-02 15:53:46
